<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3760420/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760420/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Pharmacogenetics and genomics"><meta name="citation_title" content="Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate"><meta name="citation_authors" content="Alexis C. Frazier-Wood, Stella Aslibekyan, Ingrid B. Borecki, Paul N. Hopkins, Chao-Qiang Lai, Jose M. Ordovas, Robert J. Straka, Hemant K. Tiwari, Donna K. Arnett"><meta name="citation_date" content="October 2012"><meta name="citation_issue" content="10"><meta name="citation_volume" content="22"><meta name="citation_firstpage" content="750"><meta name="citation_doi" content="10.1097/FPC.0b013e328357f6af"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3760420/?report=abstract"><meta name="citation_pmid" content="22890011"><meta name="DC.Title" content="Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Alexis C. Frazier-Wood"><meta name="DC.Contributor" content="Stella Aslibekyan"><meta name="DC.Contributor" content="Ingrid B. Borecki"><meta name="DC.Contributor" content="Paul N. Hopkins"><meta name="DC.Contributor" content="Chao-Qiang Lai"><meta name="DC.Contributor" content="Jose M. Ordovas"><meta name="DC.Contributor" content="Robert J. Straka"><meta name="DC.Contributor" content="Hemant K. Tiwari"><meta name="DC.Contributor" content="Donna K. Arnett"><meta name="DC.Date" content="2012 Oct"><meta name="DC.Identifier" content="10.1097/FPC.0b013e328357f6af"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate"><meta property="og:type" content="article"><meta property="og:description" content="A shift towards overall larger very low-density lipoprotein (VLDL), and smaller low-density lipoprotein and high-density lipoprotein (HDL) diameters occurs in insulin resistance (IR), which reflects shifts in the distribution of the subfraction concentrations. ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760420/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3760420/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3760420/pdf/nihms487636.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8AC5B0DD5457C100000000058D0393.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3760420%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3760420</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Pharmacogenet Genomics</a></span>. Author manuscript; available in PMC 2013 Oct 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22890011" target="pmc_ext" ref="reftype=publisher&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Pharmacogenet Genomics. 2012 Oct; 22(10): 750–757. </span></a></div> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1097%2FFPC.0b013e328357f6af" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1097/FPC.0b013e328357f6af</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3760420</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS487636</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22890011">22890011</a></div></div></div></div><h1 class="content-title">Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Frazier-Wood%20AC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734194903888" co-class="co-affbox">Alexis C. Frazier-Wood</a>,<sup>a,</sup><sup>b,</sup><sup>c</sup> <a href="/pubmed/?term=Aslibekyan%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734192140720" co-class="co-affbox">Stella Aslibekyan</a>,<sup>a</sup> <a href="/pubmed/?term=Borecki%20IB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734191242912" co-class="co-affbox">Ingrid B. Borecki</a>,<sup>d</sup> <a href="/pubmed/?term=Hopkins%20PN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734191241152" co-class="co-affbox">Paul N. Hopkins</a>,<sup>e</sup> <a href="/pubmed/?term=Lai%20CQ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734192460128" co-class="co-affbox">Chao-Qiang Lai</a>,<sup>f</sup> <a href="/pubmed/?term=Ordovas%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734193564096" co-class="co-affbox">Jose M. Ordovas</a>,<sup>f,</sup><sup>h,</sup><sup>i</sup> <a href="/pubmed/?term=Straka%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734198676944" co-class="co-affbox">Robert J. Straka</a>,<sup>g</sup> <a href="/pubmed/?term=Tiwari%20HK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734198674960" co-class="co-affbox">Hemant K. Tiwari</a>,<sup>b</sup> and  <a href="/pubmed/?term=Arnett%20DK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011" class="affpopup" co-rid="_co_idm139734193527936" co-class="co-affbox">Donna K. Arnett</a><sup>a</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139734194903888"><h3 class="no_margin">Alexis C. Frazier-Wood</h3><p><sup>a</sup>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama</p><p><sup>b</sup>Section on Statistical Genetics, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama</p><p><sup>c</sup>Department of Energetics, University of Alabama at Birmingham, Birmingham, Alabama</p><div>Find articles by <a href="/pubmed/?term=Frazier-Wood%20AC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Alexis C. Frazier-Wood</a></div></div><div id="_co_idm139734192140720"><h3 class="no_margin">Stella Aslibekyan</h3><p><sup>a</sup>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama</p><div>Find articles by <a href="/pubmed/?term=Aslibekyan%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Stella Aslibekyan</a></div></div><div id="_co_idm139734191242912"><h3 class="no_margin">Ingrid B. Borecki</h3><p><sup>d</sup>Department of Genetics, Washington University School of Medicine, St Louis, Missouri</p><div>Find articles by <a href="/pubmed/?term=Borecki%20IB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Ingrid B. Borecki</a></div></div><div id="_co_idm139734191241152"><h3 class="no_margin">Paul N. Hopkins</h3><p><sup>e</sup>Department of Internal Medicine, University of Utah, Salt Lake City, Utah</p><div>Find articles by <a href="/pubmed/?term=Hopkins%20PN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Paul N. Hopkins</a></div></div><div id="_co_idm139734192460128"><h3 class="no_margin">Chao-Qiang Lai</h3><p><sup>f</sup>Nutrition and Genomics Laboratory, Jean Mayer-US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts</p><div>Find articles by <a href="/pubmed/?term=Lai%20CQ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Chao-Qiang Lai</a></div></div><div id="_co_idm139734193564096"><h3 class="no_margin">Jose M. Ordovas</h3><p><sup>f</sup>Nutrition and Genomics Laboratory, Jean Mayer-US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts</p><p><sup>h</sup>The Department of Epidemiology and Population Genetics, Centro Nacional Investigación Cardiovasculares (CNIC), Madrid, Spain</p><p><sup>i</sup>IMDEA Food, Madrid, Spain</p><div>Find articles by <a href="/pubmed/?term=Ordovas%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Jose M. Ordovas</a></div></div><div id="_co_idm139734198676944"><h3 class="no_margin">Robert J. Straka</h3><p><sup>g</sup>Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA</p><div>Find articles by <a href="/pubmed/?term=Straka%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Robert J. Straka</a></div></div><div id="_co_idm139734198674960"><h3 class="no_margin">Hemant K. Tiwari</h3><p><sup>b</sup>Section on Statistical Genetics, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama</p><div>Find articles by <a href="/pubmed/?term=Tiwari%20HK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Hemant K. Tiwari</a></div></div><div id="_co_idm139734193527936"><h3 class="no_margin">Donna K. Arnett</h3><p><sup>a</sup>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama</p><div>Find articles by <a href="/pubmed/?term=Arnett%20DK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22890011">Donna K. Arnett</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139734192720912_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139734192720912_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139734192720912_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>a</sup>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama</div><div class="fm-affl" id="A2" lang="en"><sup>b</sup>Section on Statistical Genetics, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama</div><div class="fm-affl" id="A3" lang="en"><sup>c</sup>Department of Energetics, University of Alabama at Birmingham, Birmingham, Alabama</div><div class="fm-affl" id="A4" lang="en"><sup>d</sup>Department of Genetics, Washington University School of Medicine, St Louis, Missouri</div><div class="fm-affl" id="A5" lang="en"><sup>e</sup>Department of Internal Medicine, University of Utah, Salt Lake City, Utah</div><div class="fm-affl" id="A6" lang="en"><sup>f</sup>Nutrition and Genomics Laboratory, Jean Mayer-US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts</div><div class="fm-affl" id="A7" lang="en"><sup>g</sup>Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA</div><div class="fm-affl" id="A8" lang="en"><sup>h</sup>The Department of Epidemiology and Population Genetics, Centro Nacional Investigación Cardiovasculares (CNIC), Madrid, Spain</div><div class="fm-affl" id="A9" lang="en"><sup>i</sup>IMDEA Food, Madrid, Spain</div><div id="FN1">Correspondence to: Alexis C. Frazier-Wood, PhD, Department of Epidemiology, University of Alabama at Birmingham, RPHB 230P, Birmingham, Alabama 35294, USA Tel: + 1 205 975 9198; fax: + 1 205 934 8665; <a href="mailto:dev@null" data-email="moc.liamg@doowikkel" class="oemail">moc.liamg@doowikkel</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139734192720912_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22890011" target="pmc_ext" ref="reftype=publisher&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Pharmacogenet Genomics</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3760420/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplementary data.</strong></div><div><a href="/pmc/articles/PMC3760420/bin/NIHMS487636-supplement-Supplementary_data.docx" data-ga-action="click_feat_suppl">NIHMS487636-supplement-Supplementary_data.docx</a><span style="color:gray"> (1.6M)</span></div><div class="small guid">GUID:&nbsp;893C0CD3-98B3-4955-BA23-227526894572</div></div></dd></dl></div><div id="idm139734229867248" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139734229867248title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Objective</h3><p id="P1" class="p p-first-last">A shift towards overall larger very low-density lipoprotein (VLDL), and smaller low-density lipoprotein and high-density lipoprotein (HDL) diameters occurs in insulin resistance (IR), which reflects shifts in the distribution of the subfraction concentrations. Fenofibrate, indicated for hypertriglyceridemia, simultaneously reduces IR and shifts in lipoprotein diameter. Individual responses to fenofibrate vary, and we conducted a genome-wide association study to identify genetic differences that could contribute to such differences.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">Association analysis was conducted between single nucleotide polymorphisms (SNPs) on the Affymetrix 6.0 array and fasting particle diameter responses to a 12-week fenofibrate trial, in 817 related Caucasian participants of the Genetics of Lipid Lowering Drugs and Diet Network. Linear models were conducted, which adjusted for age, sex and study center as fixed effects, and pedigree as a random effect. The top three SNPs associated with each fraction were examined subsequently for associations with changes in subfraction concentrations.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">SNPs in <em>AHCYL2</em> and <em>CD36</em> genes reached, or closely approached, genome-wide levels of significance with VLDL and HDL diameter responses to fenofibrate, respectively (<em>P</em>=4 × 10<sup>−9</sup> and 8 × 10<sup>−8</sup>). SNPs in <em>AHCYL2</em> were associated with a decrease in the concentration of the large VLDL subfraction only (<em>P</em> = 0.002). SNPs associated with HDL diameter change were not associated with a single subfraction concentration change (<em>P</em> &gt; 0.05) indicating small shifts across all subfractions.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusion</h3><p id="P4" class="p p-first-last">We report novel associations between lipoprotein diameter responses to fenofibrate and the <em>AHCYL2</em> and <em>CD36</em> genes. Previous associations of these genes with IR emphasize the role of IR in mediating lipoprotein response to fenofibrate.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text"><em>AHCYL2</em>, <em>CD36</em>, fenofibrate, inflammation, insulin resistance, insulin signaling, lipoprotein diameter, methylation, <em>PPARγ</em>, subclass</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">Lipoproteins within the fractions of very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) are heterogenous in their composition. Within a given fraction, the constituent lipoprotein particles can be subdivided into several subfractions, based on size. Recent research indicates that the subfraction distribution within each fraction may be more informative in understanding lipoprotein metabolism and its associations with disease risk than traditional lipid measures [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024175">1</a>]. As lipoprotein diameters are modifiable through drug, exercise, and dietary interventions [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024181">2</a>–<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024172">4</a>], they may thus present an important epidemiological tool to understand the pathways to insulin resistance (IR) and atherosclerosis, and a clinical target for preventing the development of these conditions.</p><p id="P6">Increases in the number of small LDL and HDL particles are associated with the development of IR and atherosclerosis [<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024177">5</a>–<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024186">7</a>]. These changes in concentration are reflected as shifts to a smaller average LDL and HDL diameter [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024165">8</a>], and research has supported similar associations between IR and smaller average LDL/HDL diameters, as well as between these conditions and larger average VLDL diameter [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024196">8</a>,<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024180">9</a>]. Fenofibrate is an efficacious therapeutic agent indicated in hypertriglyceridemia, which reduces plasma triglyceride (TG) levels by 35–50% while conferring additional benefits on HDL-C concentrations and markers of inflammation [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024200">10</a>–<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024183">15</a>]. In addition, fenofibrate is associated with shift towards larger more buoyant LDL particles in a variety of populations, which is associated with a decreased progression of coronary artery disease [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024197">16</a>–<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024179">19</a>]. The effect of fenofibrate on changes in diameter in the other lipoprotein fractions is less well studied, although increases in the average HDL diameter have been reported in mice [<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024187">20</a>].</p><p id="P7" class="p p-last">There is, however, a significant interindividual variation in the response to fenofibrate across a range of lipid phenotypes [<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024202">21</a>]. Although several genes have been associated with interindividual variations in the lipid-lowering effects of fenofibrate [<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024169">22</a>–<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024191">24</a>], studies have yet to examine which genetic variants may mediate the effects of fenofibrate on the change in the distribution of the lipoprotein subfractions, reflected as a change in the average particle diameter. Genome-wide association studies (GWAS) are advantageous in understanding individual variations as the method is hypothesis free and designed to generate new hypothesis regarding underlying biological pathways. In this study, we performed association tests between single nucleotide polymorphisms (SNPs) and lipoprotein particle diameters, for each fraction of lipoprotein, before and after 3 weeks of daily treatment with fenofibrate in genetically homogeneous Caucasian participants of the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study. In addition, we examined the association of the top three loci associated with the diameter response to fenofibrate for each of VLDL, LDL, and HDL with changes in the concentration of the various subtractions, to further examine the biological change driving the SNP–phenotype associations found.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Study population</h3><p id="P8" class="p p-first">GOLDN is part of the PROgram for GENetic Interaction Network, a group of family intervention studies focusing on gene–environment interactions. The participants in the GOLDN study were mainly rerecruited from two NHLBI Family Heart Study field centers: Minneapolis (Minnesota) and Salt Lake City (Utah). All participants were of European ancestry. Eligibility criteria were: (a) at least 18 years of age; (b) fasting TGs less than 1500mg/dl; (c) willing to participate in the study and attend the scheduled clinic exams; (d) member of a family with at least two members in a sibship; (e) ASTand ALTresults within normal range; and (f) creatinine less than or equal to 2.0mg/dl. Exclusion criteria were: (a) history of liver, kidney, pancreas, gall bladder disease, or malabsorption; (b) current pregnancy; (c) insulin use; (d) use of lipid lowering drugs (including prescription, OTC and nutraceuticals; participants taking these agents were withdrawn from them ≥4 weeks before the study with physician’s approval); (e) use of warfarin; (f) women of childbearing potential not using an acceptable form of contraception; (g) known hypersensitivity to fenofibrate; and (h) history of pancreatitis within 12 months before enrollment. Previous data on these conditions were available from the parent study, and individuals not fulfilling inclusion criteria were not invited to participate. A medication questionnaire was administered on the first visit, which confirmed eligibility for inclusion. A previous study demonstrated that Caucasians in Utah and Minnesota were homogeneous and pooling data across centers would not threaten the validity of this study [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024176">25</a>]. From an initial sample size of 1 238 participants 817 agreed to undergo the fenofibrate trial and are included in the analysis.</p><p id="P9" class="p p-last">The details of the GOLDN visits are published elsewhere [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024190">26</a>] and depicted in <a href="/pmc/articles/PMC3760420/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>. After granting informed consent, participants underwent a baseline screening visit. This visit included a fasting blood draw and pregnancy test, if applicable. The day before the first clinical exam, participants came to the clinic for a fasting blood draw. The fenofibrate intervention consisted of a 3-week treatment period, in which participants took fenofibrate (160mg) daily. Lipoproteins were measured twice on the last 2 days of the treatment period after a minimum 8-h fast.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3760420/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734199418416" class="figure"><a href="/pmc/articles/PMC3760420/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3760420_nihms487636f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms487636f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3760420/bin/nihms487636f1.jpg"></a></div><div id="largeobj_idm139734199418416" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3760420/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="__p5">Details of the GOLDN study. Reproduced with permission from Frazier-Wood <em>et al</em>. [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024173">26</a>]. AE, adverse events; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network.</p></div></div></div></div><div id="S8" class="sec"><h3 id="S8title">Biochemical measurements</h3><p id="P10" class="p p-first-last">All plasma samples used for this analysis were collected after an 8-h fast. All samples were analyzed for lipoprotein profiles once all collections were carried out in each study. Measurements of VLDL, LDL, and HDL diameter were determined by nuclear magnetic resonance (NMR) spectroscopy. NMR detects the signal emitted by lipoprotein methyl-group protons when in the field of a magnet charged at 400MHz. The NMR signal is decoded to obtain estimates of particle numbers for each of several lipoprotein fractions. The weighted average particle diameter for each lipoprotein fraction (VLDL, LDL, and HDL) is calculated as the sum of the average lipoprotein particle diameters multiplied by the relative mass percentage, based on the amplitude of the methyl NMR signal (nm). NMR groups intermediate-density lipoproteins as a subclass of LDL [<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024174">27</a>,<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024199">28</a>]. Details of the range of diameters within each subfraction are given in <a href="/pmc/articles/PMC3760420/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p6">Diameter ranges of lipoprotein subclasses when measured by NMR</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734199415840" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="left">NMR lipoprotein parameter</th><th rowspan="1" colspan="1" valign="bottom" align="center">Diameter range (nm)</th></tr></thead><tbody><tr><td colspan="2" rowspan="1" valign="top" align="left">VLDL</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Large VLDL/chylomicrons</td><td rowspan="1" colspan="1" valign="top" align="center">&gt; 60</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Medium VLDL</td><td rowspan="1" colspan="1" valign="top" align="center">35–60</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Small VLDL</td><td rowspan="1" colspan="1" valign="top" align="center">27–35</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">LDL</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Large LDL</td><td rowspan="1" colspan="1" valign="top" align="center">21.2–23</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Small LDL</td><td rowspan="1" colspan="1" valign="top" align="center">18–21.2</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Medium–small LDL</td><td rowspan="1" colspan="1" valign="top" align="center">19.8–21.2</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Very small LDL</td><td rowspan="1" colspan="1" valign="top" align="center">18–19.8</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">HDL</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Large HDL</td><td rowspan="1" colspan="1" valign="top" align="center">8.8–13</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Medium HDL</td><td rowspan="1" colspan="1" valign="top" align="center">8.2–8.8</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Small HDL</td><td rowspan="1" colspan="1" valign="top" align="center">7.3–8.2</td></tr></tbody></table></div><div id="largeobj_idm139734199415840" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p7" class="p p-first-last">Adapted from Jeyarajah <em>et al</em>. [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024188">28</a>].</p></div><div id="TFN2"><p id="__p8" class="p p-first-last">HDL, high-density lipoprotein; LDL, low-density lipoprotein; NMR, nuclear magnetic resonance; VLDL, very low-density lipoprotein.</p></div></div></div></div><div id="S9" class="sec"><h3 id="S9title">Genotyping</h3><p id="P11" class="p p-first-last">DNA extraction and purification in the GOLDN study has been described in detail by Irvin <em>et al</em>. [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024166">29</a>]. A total of 9 06 600 SNPs were genotyped using the Affymetrix Genome-Wide Human 6.0 array (Affymetrix Inc., Santa Clara, California, USA) and the Birdseed calling algorithm (Broad Institute, Cambridge, Massachusetts, USA) [<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024184">30</a>]. The samples were processed in two different batches by two different technicians. After the imputation, we created a hybrid dataset that included 2 543 887 SNPs, of which 584 029 were initially genotyped in the GOLDN population. SNPs that were monomorphic (55 530) or had a call rate less than 96% (82 462) were removed from the analysis. In addition, SNPs were excluded from the analysis based on the number of families with Mendelian errors as follows: for minor allele frequency (MAF) of at least 20%, removed if errors were present in more than three families (1486 SNPs); for 20%&gt;MAF≥10%, removed if errors were present in more than two families (1338 SNPs); for 10%&gt;MAF≥5%, removed if errors were present in more than one family (1767 SNPs); for MAF less than 5%, removed if any errors were present (9592 SNPs). In families with remaining errors, the SNPs that showed a Mendelian error were considered as missing (31 595 SNPs). Furthermore, 16 participants with call rates less than 96% were also removed from any subsequent analyses. Subsequently, 748 SNPs failing the Hardy–Weinberg equilibrium test at <em>P</em>-value less than 10<sup>−6</sup> were excluded from association analyses. Finally, after excluding markers with MAF less than 1%, Hardy–Weinberg equilibrium (<em>P</em>&lt;10<sup>−6</sup>), missing strand information, or discrepancies with the <em>mlinfo</em> file, we used the MACH software (version 1.0.16) to impute untyped SNPs using Human Genome Build 36, CEU population, as the reference [<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024168">31</a>,<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024182">32</a>]. Missing typed data were considered as missing in the final genotype dataset.</p></div><div id="S10" class="sec sec-last"><h3 id="S10title">Statistical methods</h3><p id="P12" class="p p-first">Outcomes were defined using predicted values from linear regression models (slopes). Where necessary, data were monotonically transformed prefenofibrate and postfenofibrate to normalize the distribution (further details found in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>, <a href="http://links.lww.com/FPC/A496" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A496</a>). For raw or normalized data, fasting data from visit 4 (prefenofibrate; <a href="/pmc/articles/PMC3760420/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>) was the outcome, and fasting data from visit 2 (postfenofibrate; <a href="/pmc/articles/PMC3760420/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>) along with age, sex, number of fenofibrate tablets taken per day, and data collection center were predictors.</p><div id="S11" class="sec"><p></p><h4 id="S11title" class="inline">Tests of genome-wide association </h4><p id="P13" class="p p-first-last">For the initial GWAS, the associations of interest were assessed using linear mixed models, adjusted for sex, age, and center as fixed effects, and phenotypic dependence among family members as a function of their kinship (R software, <em>kinship</em> package [<a href="#R33" rid="R33" class=" bibr popnode">33</a>]). The additive assumption was used to model genotypes. Population substructure was assessed using principal components generated using EIGENSOFT 3.0 software (<a href="http://www.genepath.med.harvard.edu/~reich/Software.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.genepath.med.harvard.edu/~reich/Software.htm</a>). As the first 10 principal components did not show a significant association with any outcome (<em>P</em>&lt;0.001), they were not included in the mixed models that tested for genotype–phenotype associations. For the initial GWAS, the Bonferroni correction was used to establish genome-wide significance, with the threshold of <em>P</em> less than 2 × 10<sup>−8</sup>. Genome-wide Manhattan plots were generated to visualize the results (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1</a>, <a href="http://links.lww.com/FPC/A498" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A498</a>). Quantile–quantile plots were constructed to evaluate deviations from the expected test statistic distribution (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 2</a>, <a href="http://links.lww.com/FPC/A499" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A499</a>). Plots of the top three hits for each phenotype were completed using LocusZoom [<a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024193">34</a>] (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 3</a>, <a href="http://links.lww.com/FPC/A500" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A500</a>).</p></div><div id="S12" class="sec"><p></p><h4 id="S12title" class="inline">Post-hoc associations with subfractions </h4><p id="P14" class="p p-first-last">The same models were used in R, with the kinship package. Because of the strong <em>a priori</em> hypothesis a false discovery rate (FDR) correction was used on all significant results (<em>P</em>&lt;0.05) within each fraction and corrected Q values are additionally presented [<a href="#R35" rid="R35" class=" bibr popnode">35</a>].</p></div><div id="S13" class="sec sec-last"><p></p><h4 id="S13title" class="inline">Gene set-based analysis </h4><p id="P15" class="p p-first-last">A pathway analysis on the results of the GWAS were analyzed using the program gene set-based analysis of polymorphisms (GeSBAP [<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024195">36</a>]). GeSBAP maps SNPs onto gene (±5 kb) using HapMap data. A gene set-based test is conducted [<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024198">37</a>] whereby the SNPs that fall within a category defined by Gene Ontology (GO [<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024201">38</a>]) are combined into a single <em>P</em>-value for that category, corrected for multiple testing using an FDR correction [<a href="#R35" rid="R35" class=" bibr popnode">35</a>]. In addition, the percentage of genes within the GO category that are significantly associated with the phenotype in a gene-based test is given (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 4</a>, <a href="http://links.lww.com/FPC/A502" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A502</a>). To avoid overinterpreting the data, although all results are presented, we discuss only those where the <em>P</em>-value for the biological pathway was significant at an FDR corrected <em>P</em> less than 0.01 and 100% of the genes within the GO biological pathway were significantly associated with the phenotype at an FDR-corrected <em>P</em> less than 0.01.</p></div></div></div><div id="S14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S14title">Results</h2><p id="P16" class="p p-first">General characteristics of the GOLDN study population are summarized in <a href="/pmc/articles/PMC3760420/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>. Half of the participants were female (50.8%). All participants were of European ancestry. In both the prefenofibrate and postfenofibrate conditions, there were no significant differences between men and women for demographic variables or fasting VLDL diameter; however, fasting LDL and HDL diameters varied significantly by sex (both <em>P</em>&lt;0.001). Change in lipoprotein diameter from prefenofibrate to postfenofibrate was significantly different for LDL (Δ=0.12±0.80 nm; <em>P</em>&lt;0.0001) and HDL (Δ=0.12±0.23nm; <em>P</em>&lt;0.0001) diameter, but not VLDL diameter (Δ=0.49±9.17nm; <em>P</em>=0.12).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p9">Means (±SD) or percentages for demographic characteristics and lipoprotein diameters for the GOLDN study participants</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734192629744" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="left"></th><th rowspan="1" colspan="1" valign="bottom" align="center">Men</th><th rowspan="1" colspan="1" valign="bottom" align="center">Women</th><th rowspan="1" colspan="1" valign="bottom" align="center"></th><th rowspan="1" colspan="1" valign="bottom" align="left"><em>P</em><sup>a</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Age (years)</td><td rowspan="1" colspan="1" valign="top" align="center">48.3 (15.6)</td><td rowspan="1" colspan="1" valign="top" align="center">48.1 (15.9)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="left">0.57</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Field center (% from Minnesota)</td><td rowspan="1" colspan="1" valign="top" align="center">49.6</td><td rowspan="1" colspan="1" valign="top" align="center">49.6</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="left">0.89</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age (years)</td><td rowspan="1" colspan="1" valign="top" align="center">48.3 (15.6)</td><td rowspan="1" colspan="1" valign="top" align="center">48.1 (15.9)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="left">0.57</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"></td><td colspan="3" rowspan="1" valign="bottom" align="center">Men and women
<hr></td><td rowspan="1" colspan="1" valign="top" align="left"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center">Prefenofibrate</td><td rowspan="1" colspan="1" valign="top" align="center">Postfenofibrate</td><td rowspan="1" colspan="1" valign="top" align="center">Δ</td><td rowspan="1" colspan="1" valign="top" align="left"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">VLDL diameter (nm)</td><td rowspan="1" colspan="1" valign="top" align="center">51.39 (7.83)</td><td rowspan="1" colspan="1" valign="top" align="center">51.87 (8.73)</td><td rowspan="1" colspan="1" valign="top" align="center">0.49 (9.17)</td><td rowspan="1" colspan="1" valign="top" align="left">0.12</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">LDL diameter (nm)</td><td rowspan="1" colspan="1" valign="top" align="center">20.80 (0.88)</td><td rowspan="1" colspan="1" valign="top" align="center">20.89 (0.58)</td><td rowspan="1" colspan="1" valign="top" align="center">0.12 (0.80)</td><td rowspan="1" colspan="1" valign="top" align="left">&lt; 0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">HDL diameter (nm)</td><td rowspan="1" colspan="1" valign="top" align="center">8.85 (0.85)</td><td rowspan="1" colspan="1" valign="top" align="center">8.73 (0.40)</td><td rowspan="1" colspan="1" valign="top" align="center">0.12 (0.23)</td><td rowspan="1" colspan="1" valign="top" align="left">&lt; 0.0001</td></tr></tbody></table></div><div id="largeobj_idm139734192629744" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><p id="__p10" class="p p-first-last">GOLDN, Genetics of Lipid Lowering Drugs and Diet Network; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.</p></div><div id="TFN4"><sup>a</sup><em>P</em>-values examining differences in diameters were derived from <em>t</em>-tests.</div></div></div><div id="S15" class="sec"><h3 id="S15title">Initial GWAS</h3><p id="P17" class="p p-first-last">The top three loci for SNP associations with the prefenofibrate to postfenofibrate treatment differences for each lipoprotein diameter are described in <a href="/pmc/articles/PMC3760420/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. Variants in the S-adenosylhomocysteine hydrolase-like 2 isoform (<em>AHCYL2</em>) gene, and the CD36 antigen (<em>CD36</em>) genes reached (or nearly approached) genome-wide levels of significance with VLDL and HDL diameter responses to fenofibrate, respectively (<em>P</em>=3.95 × 10<sup>−9</sup> and 7.52 × 10<sup>−8</sup>). The next top two loci reported for each of the fraction are within the cytokinesis 4 (<em>DOCK4</em>) gene with VLDL diameter response (<em>P</em>=1.39 × 10<sup>−7</sup> and 1.45 × 10<sup>−7</sup>), and within the peroxisome proliferator-activated receptor (<em>PPARγC1B</em>) gene for HDL diameter response to fenofibrate (<em>P</em>=2.87 × 10<sup>−7</sup>). Although there were no associations reaching genome-wide levels of significance with LDL diameter response to fenofibrate, the top three loci were in the jumonji domain containing 1C isoform a (<em>JMJD1C</em>) gene (<em>P</em>=1.81 × 10<sup>−6</sup>), the phosphodiesterase 10A (<em>PDE10</em>) gene (<em>P</em>=2.01 × 10<sup>−6</sup>) and near the neurexophilin-1 (<em>NXPH1</em>) gene (<em>P</em>=1.45 × 10<sup>−06</sup>). As the two SNPs in the DOCK4 gene were in high LD (<em>r</em>&gt;0.8) conditional analysis was run whereby both SNPs were simultaneously modeled as predictors. In this model, neither SNP remained significant (rs10428959: <em>P</em>=0.32; rs6466397: <em>P</em>=0.34), suggesting that either could be causal or they could be tagging the causal variant. There were no other SNPs in LD&gt;<em>r</em>=0.03 in our data, and therefore this question remains open.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p12">Top three genetic loci in SNP-phenotype associations with VLDL, LDL and HDL particle diameter changes in response to fenofibrate in GOLDN study participants</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734195590016" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="left">Marker</th><th rowspan="1" colspan="1" valign="bottom" align="right">Chromosome</th><th rowspan="1" colspan="1" valign="bottom" align="right">Position</th><th rowspan="1" colspan="1" valign="bottom" align="left">HWE</th><th rowspan="1" colspan="1" valign="bottom" align="center">Minor allele</th><th rowspan="1" colspan="1" valign="bottom" align="right"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center">Gene</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th></tr></thead><tbody><tr><td colspan="8" rowspan="1" valign="top" align="left">VLDL diameter</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs11766298</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">128792083</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="right">4.41 (0.74)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>AHCLY2</em></td><td rowspan="1" colspan="1" valign="top" align="center">3.95 × 10<sup>−9</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs10428959</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">111465142</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="right">6.00 (1.13)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>DOCK4</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.39 × 10<sup>−7</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs6466397</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">111454471</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="right">−5.98 (1.13)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>DOCK4</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.45 × 10<sup>−7</sup></td></tr><tr><td colspan="8" rowspan="1" valign="top" align="left">LDL diameter</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs10952132</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">9033345</td><td rowspan="1" colspan="1" valign="top" align="left">&gt; 0.99</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="right">0.31 (0.64)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>NXPH1</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.45 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs10995485</td><td rowspan="1" colspan="1" valign="top" align="right">10</td><td rowspan="1" colspan="1" valign="top" align="right">64696864</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="right">−1.18 (0.25)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>JMJ1C</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.81 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs519595</td><td rowspan="1" colspan="1" valign="top" align="right">6</td><td rowspan="1" colspan="1" valign="top" align="right">165855411</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="right">−0.60 (0.12)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>PDE10</em></td><td rowspan="1" colspan="1" valign="top" align="center">2.01 × 10<sup>−6</sup></td></tr><tr><td colspan="8" rowspan="1" valign="top" align="left">HDL diameter</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs11574703</td><td rowspan="1" colspan="1" valign="top" align="right">7</td><td rowspan="1" colspan="1" valign="top" align="right">80124844</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="right">−3.72 (0.68)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>CD36</em></td><td rowspan="1" colspan="1" valign="top" align="center">7.52 × 10<sup>−8</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs5001812</td><td rowspan="1" colspan="1" valign="top" align="right">2</td><td rowspan="1" colspan="1" valign="top" align="right">166412540</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="right">−4.67 (0.89)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">2.17 × 10<sup>−7</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> rs9285640</td><td rowspan="1" colspan="1" valign="top" align="right">5</td><td rowspan="1" colspan="1" valign="top" align="right">149122260</td><td rowspan="1" colspan="1" valign="top" align="left">–</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="right">−29.95 (5.78)</td><td rowspan="1" colspan="1" valign="top" align="center"><em>PPARγC1B</em></td><td rowspan="1" colspan="1" valign="top" align="center">2.87 × 10<sup>−7</sup></td></tr></tbody></table></div><div id="largeobj_idm139734195590016" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><p id="__p13" class="p p-first-last">GOLDN, Genetics of Lipid Lowering Drugs and Diet Network; HDL, high-density lipoprotein; HWE, Hardy–Weinberg equilibrium; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein.</p></div></div></div></div><div id="S16" class="sec"><h3 id="S16title">Post-hoc associations with subfractions</h3><p id="P18" class="p p-first">The decrease in VLDL diameter, associated with variants in the <em>AHCYL2</em> and <em>DOCK4</em> genes reflected an association of these variants with a decrease in the concentration of large VLDL particles (<em>P</em>=0.002–0.02; <em>Q</em>=0.01–0.06); these variants were not associated with changes in the concentration of medium or small VLDL particles (<em>P</em>&gt;0.05; <a href="/pmc/articles/PMC3760420/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>). The top three loci associated with an increase in LDL diameter reflected similar associations between these loci and changes across all five subfractions of the LDL fraction (all <em>P</em>&lt;0.02; <em>Q</em>&lt;0.02; <a href="/pmc/articles/PMC3760420/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>). Finally, the associations of HDL diameter response to fenofibrate with variants in the <em>CD36</em> and <em>PPARγC1B</em> genes seem to reflect small changes across all subfraction concentrations, and are not driven by significant changes in the concentration of any of the HDL subfractions (all <em>P</em>&gt;0.05; <a href="/pmc/articles/PMC3760420/table/T6/" target="table" class="fig-table-link figpopup" rid-figpopup="T6" rid-ob="ob-T6" co-legend-rid=""><span>Table 6</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p14">The association of the top three genetic loci in SNP-phenotype associations VLDL particle diameters response to fenofibrate with VLDL subfraction concentration responses to fenofibrate</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734229983840" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="left">Marker</th><th colspan="3" rowspan="1" valign="bottom" align="center">Large VLDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Medium VLDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Small VLDL
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="left"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11766298</td><td rowspan="1" colspan="1" valign="top" align="center">1.86 (0.78)</td><td rowspan="1" colspan="1" valign="top" align="left">0.02</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">−1.40 (0.77)</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">−1.12 (0.90)</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10428959</td><td rowspan="1" colspan="1" valign="top" align="center">3.58 (1.14)</td><td rowspan="1" colspan="1" valign="top" align="left">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">−1.32 (1.16)</td><td rowspan="1" colspan="1" valign="top" align="center">0.26</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">−1.02 (1.39)</td><td rowspan="1" colspan="1" valign="top" align="center">0.46</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6466397</td><td rowspan="1" colspan="1" valign="top" align="center">−3.58 (1.14)</td><td rowspan="1" colspan="1" valign="top" align="left">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td><td rowspan="1" colspan="1" valign="top" align="center">1.31 (1.16)</td><td rowspan="1" colspan="1" valign="top" align="center">0.26</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">1.02 (1.39)</td><td rowspan="1" colspan="1" valign="top" align="center">0.46</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr></tbody></table></div><div id="largeobj_idm139734229983840" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN6"><p id="__p15" class="p p-first-last">SNPs, single nucleotide polymorphisms; VLDL, very low-density lipoprotein.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p16">The association of the top three genetic loci in SNP-phenotype associations LDL particle diameters response to fenofibrate with LDL subfraction concentration responses to fenofibrate</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734192403792" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="left">Marker</th><th colspan="3" rowspan="1" valign="bottom" align="center">Large LDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Medium–small LDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Small LDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Very small LDL
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10952132</td><td rowspan="1" colspan="1" valign="top" align="center">0.29 (0.65)</td><td rowspan="1" colspan="1" valign="top" align="center">7.31 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.00 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">−0.16 (0.69)</td><td rowspan="1" colspan="1" valign="top" align="center">0.02</td><td rowspan="1" colspan="1" valign="top" align="center">0.02</td><td rowspan="1" colspan="1" valign="top" align="center">−0.29 (0.07)</td><td rowspan="1" colspan="1" valign="top" align="center">2.26 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.8 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">−0.29 (0.07)</td><td rowspan="1" colspan="1" valign="top" align="center">4.13 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">6.85 × 10<sup>−5</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10995485</td><td rowspan="1" colspan="1" valign="top" align="center">−1.04 (0.25)</td><td rowspan="1" colspan="1" valign="top" align="center">3.35 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">6.00 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.12 (0.25)</td><td rowspan="1" colspan="1" valign="top" align="center">1.16 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.00 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.82 (0.26)</td><td rowspan="1" colspan="1" valign="top" align="center">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.75 (0.27)</td><td rowspan="1" colspan="1" valign="top" align="center">0.006</td><td rowspan="1" colspan="1" valign="top" align="center">0.007</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs519595</td><td rowspan="1" colspan="1" valign="top" align="center">−0.58 (0.13)</td><td rowspan="1" colspan="1" valign="top" align="center">5.02 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.00 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.44 (0.14)</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td><td rowspan="1" colspan="1" valign="top" align="center">0.58 (0.13)</td><td rowspan="1" colspan="1" valign="top" align="center">1.17 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.00 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.52 (0.14)</td><td rowspan="1" colspan="1" valign="top" align="center">0.0002</td><td rowspan="1" colspan="1" valign="top" align="center">3.00 × 10<sup>−4</sup></td></tr></tbody></table></div><div id="largeobj_idm139734192403792" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN7"><p id="__p17" class="p p-first-last">LDL, low-density lipoprotein; SNPs, single nucleotide polymorphisms.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T6"><h3>Table 6</h3><!--caption a7--><div class="caption"><p id="__p18">The association of the top three genetic loci in SNP-phenotype associations HDL particle diameters response to fenofibrate with HDL subfraction concentration responses to fenofibrate</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139734269737072" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="left">Marker</th><th colspan="3" rowspan="1" valign="bottom" align="center">Large HDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Medium HDL
<hr></th><th colspan="3" rowspan="1" valign="bottom" align="center">Small HDL
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th><th rowspan="1" colspan="1" valign="bottom" align="right"><em>β</em> (SE)</th><th rowspan="1" colspan="1" valign="bottom" align="left"><em>P</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">Q</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11574703</td><td rowspan="1" colspan="1" valign="top" align="center">−0.62 (0.70)</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">1.85 (1.23)</td><td rowspan="1" colspan="1" valign="top" align="center">0.13</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="right">0.24 (0.69)</td><td rowspan="1" colspan="1" valign="top" align="left">0.73</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs5001812</td><td rowspan="1" colspan="1" valign="top" align="center">−1.09 (0.91)</td><td rowspan="1" colspan="1" valign="top" align="center">0.23</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">−0.66 (1.99</td><td rowspan="1" colspan="1" valign="top" align="center">0.75</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="right">2.77 (0.90)</td><td rowspan="1" colspan="1" valign="top" align="left">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9285640</td><td rowspan="1" colspan="1" valign="top" align="center">3.45 (5.88)</td><td rowspan="1" colspan="1" valign="top" align="center">0.56</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="center">−13.27 (15.73)</td><td rowspan="1" colspan="1" valign="top" align="center">0.39</td><td rowspan="1" colspan="1" valign="top" align="center">–</td><td rowspan="1" colspan="1" valign="top" align="right">7.33 (5.85)</td><td rowspan="1" colspan="1" valign="top" align="left">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">–</td></tr></tbody></table></div><div id="largeobj_idm139734269737072" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3760420/table/T6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN8"><p id="__p19" class="p p-first-last">HDL, high-density lipoprotein; SNPs, single nucleotide polymorphisms.</p></div></div></div><p id="P19" class="p p-last">There were no associations (FDR corrected <em>Q</em>&gt;0.10) between any of our lipoprotein diameter responses to fenofibrate with the 95 SNPs recently reported as being associated with fasting HDL-cholesterol, LDL-cholesterol, total cholesterol, or TG levels in a recent meta-analysis of 46 GWAS of these traits ([<a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024170">39</a>]; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a>, <a href="http://links.lww.com/FPC/A503" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A503</a>).</p></div><div id="S17" class="sec sec-last"><h3 id="S17title">Gene-based analysis</h3><p id="P20" class="p p-first-last">GeSBAP identified a number of biological pathways implicated in lipoprotein diameter response to fenofibrate (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 4</a>, <a href="http://links.lww.com/FPC/A502" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://links.lww.com/FPC/A502</a>). Gene sets where 100% of the GO biological pathways were significantly associated with one of the phenotypes showed that neuron adhesion pathways (<em>P</em>=4.1 × 10<sup>−2</sup>) were associated with the response of LDL diameter to fenofibrate, and pathways regulating insulin receptor signaling (<em>P</em>=1.9 × 10<sup>−2</sup>) and interleukin-6 (IL-6; <em>P</em>=4.6 × 10<sup>−3</sup>) were associated with HDL diameter responses to fenofibrate. There were no gene categories where 100% of the included genes were significantly associated with VLDL diameter response to fenofibrate.</p></div></div><div id="S18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S18title">Discussion</h2><p id="P21" class="p p-first">This is, to our knowledge, the first study to look at genetic associations with lipoprotein subfraction responses to fenofibrate. We used the GWAS data as a discovery mechanism to reveal associations between a variant in the <em>AHCYL2</em> gene with VLDL diameter response to fenofibrate, which reached genome-wide levels of significance. In addition, variants in the <em>CD36</em>, <em>PPARγC1B,</em> and <em>JMJD1C</em> genes were associated with HDL (<em>CD36</em>, <em>PPARγC1B</em>) and LDL (<em>JMJD1C</em>) diameter responses to fenofibrate, at levels approaching genome-wide significance, and may have biological relevance through previous associations with NMR and IR phenotypes.</p><p id="P22">We saw one locus that was associated with particle diameter responses to fenofibrate at genome-wide levels of significance. The response of VLDL diameter to fenofibrate was significantly associated with a single variant (rs11766298) in the <em>AHCYL2</em> gene on chromosome 7. The association of <em>AHCYL2</em> with VLDL diameter change results from decreases in the concentration of large VLDL particles also associated with <em>AHCYL2.</em> The protein encoded by <em>AHCYL2</em> acts as a homotetramer and may be involved in the conversion of S-adenosylhomocysteine to L-homocysteine and adenosine. High levels of S-adenosylhomocysteine inhibit methylation [<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024164">40</a>], are associated with IR [<a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024171">41</a>] and may be a sensitive indicator of CVD [<a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024189">42</a>].</p><p id="P23">An intronic variant of the <em>CD36</em> gene (rs11574703) was suggestively associated with a change in diameter for HDL particles, in that the association approached genome-wide levels of significance. The various subfractions of lipoprotein compete to bind in their oxidized state to the CD36 receptor, which thus may contribute to the regulation of lipid metabolism, and to the pathogenesis of atherosclerosis [<a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024185">43</a>]. Null mutations in the <em>CD36</em> gene, in mice, are associated with an increase in cholesterol, mainly within the HDL fraction, and additionally an increase in triacylglycerol within the very small LDL fraction [<a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024178">44</a>]. Our study is the first study to suggest that CD36 mutations may affect the response of the content of HDL lipoproteins to fenofibrate, in humans.</p><p id="P24">In addition, two variants approached genome-wide levels of significance (<em>P</em>&lt;2 × 10<sup>−6</sup>) and warrant further examination in their association with the fenofibrate responses of particle diameters, because of the previous associations with related phenotypes. We observed associations with markers in the <em>PPARγC1B</em> (rs9285640) gene with HDL response to fenofibrate and in the intronic region of <em>JMJ1C</em> (rs10995485) gene with LDL diameter response to fenofibrate. <em>PPARγC1B</em> has been associated previously with the homeostatic model assessment of IR, lipid-induced IR and type 2 diabetes [<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024192">45</a>–<a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024167">48</a>]. As our analysis suggests that <em>PPARγC1B</em> mediates the effect of fenofibrate, the role of IR, similarly associated with <em>PPARγC1B</em>, in mediating the responses of lipoproteins to fenofibrate should be further examined. The preliminary evidence that polymorphisms associated IR may mediate lipoprotein diameter responses to fenofibrate is strengthened by our gene set-based analysis which showed that the insulin signaling receptor biological pathway, as well as the IL-6 inflammation pathway, were associated with HDL diameter response to fenofibrate. The nominal association of <em>JMJ1C</em> with VLDL diameter response to fenofibrate is interesting as <em>JMJC1</em> has been associated previously with total number of VLDL parameters (particle concentration) in a recent GWAS [<a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_331024194">49</a>]. This GWAS report represented first lipoprotein-related association with this gene, and here we additionally report that <em>JMJ1C</em> may also associate with LDL subfraction response to fenofibrate, whereby the changes in concentration of all subfractions of LDL are mediated by individual differences in variants on the <em>JMJ1C</em> gene.</p><p id="P25">Our study should be seen in the light of a number of possible limitations. First, we limited our analysis to Caucasians of European descent at an <em>a priori</em> lower risk of cardiovascular disease, thus generalizations from our findings may be limited. Second, we assumed an additive genetic model, and thus may have missed loci that associate with fenofibrate response through other modes of inheritance, and any epistatic genetic effects. Third, information on covariates that may affect fenofibrate response, such as renal function, was limited in our cohort; therefore, we are unable to more finely understand the biology underlying our top hits. Fourth, while we consider our sample size excellent for a clinical trial, it is more modest for a current day GWAS; therefore lack of power may explain why only one hit reached genome-wide significance, and we hope the data here may inform more targeted follow-up studies. Finally, as this is the first study to examine genome-wide predictors of NMR responses to fenofibrate, replication remains a key issue. However, this is especially challenging in the context of both a clinical trial, and with the use of the newer phenotypes revealed through NMR data, which may be unavailable in existing datasets. We are unaware of any be other studies holding NMR, GWAS, and fenofibrate response data. Thus, as the results from the gene-based analysis support our GWAS findings and fit with previous biological findings from independent groups, they are exploratory and should be considered suggestive only, and a basis for future research paradigms.</p><p id="P26" class="p p-last">Nonetheless, we provide here important evidence that genetic variants in the <em>AHCLY2</em>, <em>PPARγC1B</em>, and <em>JMJ1C</em> genes are suggestively associated with the responses of particle diameters to fenofibrate. In particular, a variant associated previously with the conversion of S-adenosylhomocysteine to L-homocysteine and adenosine, and variants involved in the insulin receptor signaling pathway and the IL-6 inflammation related pathways may be an important mediator of responses to fenofibrate. As lipoprotein diameters could present a therapeutic target in clinical interventions for IR and atherosclerosis, the associations of these genes, and the role these biological pathways may play in preventing incident disease under therapeutic interventions, warrants further research.</p></div><div id="S19" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supplementary data</h4><div class="sup-box half_rhythm" id="d36e831"><a href="/pmc/articles/PMC3760420/bin/NIHMS487636-supplement-Supplementary_data.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.6M, docx)</sup></div></div></div><div id="S20" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Acknowledgments</h2><div class="sec"><p id="__p1">GOLDN is funded by National Heart, Lung, and Blood Institute grant U01HL072524-04.</p></div></div><div id="idm139734195843584" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139734195843584title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"></p><p id="__p2" class="p p-first-last"><a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental digital content</a> is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Website (<a href="http://www.pharmacogeneticsandgenomics.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.pharmacogeneticsandgenomics.com</a>).</p><p></p><p class="fn sec" id="FN3"> </p><p id="__p3" class="p p-first"><strong>Conflicts of interest</strong></p><p id="__p4" class="p p-last">There are no conflicts of interest.</p><p></p></div></div><div id="idm139734195652608" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139734195652608title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Petersen AK, Stark K, Musameh MD, Nelson CP, Römisch-Margl W, Kremer W, et al.  Genetic associations with lipoprotein subfractions provide information on their biological nature. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1433–1443.</span> [<a href="/pubmed/22156577" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Genetic+associations+with+lipoprotein+subfractions+provide+information+on+their+biological+nature&amp;author=AK+Petersen&amp;author=K+Stark&amp;author=MD+Musameh&amp;author=CP+Nelson&amp;author=W+Römisch-Margl&amp;volume=21&amp;publication_year=2012&amp;pages=1433-1443&amp;pmid=22156577&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Lemieux I, Laperrière L, Dzavik V, Tremblay G, Bourgeois J, Després JP, et al.  A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients. <span><span class="ref-journal">Atherosclerosis. </span>2002;<span class="ref-vol">162</span>:363–371.</span> [<a href="/pubmed/11996956" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=A+16-week+fenofibrate+treatment+increases+LDL+particle+size+in+type+IIA+dyslipidemic+patients&amp;author=I+Lemieux&amp;author=L+Laperrière&amp;author=V+Dzavik&amp;author=G+Tremblay&amp;author=J+Bourgeois&amp;volume=162&amp;publication_year=2002&amp;pages=363-371&amp;pmid=11996956&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Dreon DM, Fernstrom HA, Williams PT, Tremblay G, Bourgeois J, Després JP. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. <span><span class="ref-journal">Am J Clin Nutr. </span>2000;<span class="ref-vol">71</span>:1611–1616.</span> [<a href="/pubmed/10837306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;title=Reduced+LDL+particle+size+in+children+consuming+a+very-low-fat+diet+is+related+to+parental+LDL-subclass+patterns&amp;author=DM+Dreon&amp;author=HA+Fernstrom&amp;author=PT+Williams&amp;author=G+Tremblay&amp;author=J+Bourgeois&amp;volume=71&amp;publication_year=2000&amp;pages=1611-1616&amp;pmid=10837306&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Williams PT, Krauss RM, Vranizan KM, Albers JJ, Wood PD. Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. <span><span class="ref-journal">Metabolism. </span>1992;<span class="ref-vol">41</span>:441–449.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2834280/">PMC free article</a>]</span> [<a href="/pubmed/1556953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=Effects+of+weight-loss+by+exercise+and+by+diet+on+apolipoproteins+A-I+and+A-II+and+the+particle-size+distribution+of+high-density+lipoproteins+in+men&amp;author=PT+Williams&amp;author=RM+Krauss&amp;author=KM+Vranizan&amp;author=JJ+Albers&amp;author=PD+Wood&amp;volume=41&amp;publication_year=1992&amp;pages=441-449&amp;pmid=1556953&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>2000;<span class="ref-vol">20</span>:2140–2147.</span> [<a href="/pubmed/10978261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&amp;title=The+metabolic+syndrome,+LDL+particle+size,+and+atherosclerosis:+the+Atherosclerosis+and+Insulin+Resistance+(AIR)+study&amp;author=J+Hulthe&amp;author=L+Bokemark&amp;author=J+Wikstrand&amp;author=B+Fagerberg&amp;volume=20&amp;publication_year=2000&amp;pages=2140-2147&amp;pmid=10978261&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, et al.  Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1997;<span class="ref-vol">17</span>:2713–2720.</span> [<a href="/pubmed/9409247" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&amp;title=Relation+of+LDL+size+to+the+insulin+resistance+syndrome+and+coronary+heart+disease+in+American+Indians.+The+Strong+Heart+Study&amp;author=RS+Gray&amp;author=DC+Robbins&amp;author=W+Wang&amp;author=JL+Yeh&amp;author=RR+Fabsitz&amp;volume=17&amp;publication_year=1997&amp;pages=2713-2720&amp;pmid=9409247&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC, Jr, et al.  LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) <span><span class="ref-journal">Atherosclerosis. </span>2007;<span class="ref-vol">192</span>:211–217.</span> [<a href="/pubmed/16765964" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=LDL+particle+subclasses,+LDL+particle+size,+and+carotid+atherosclerosis+in+the+Multi-Ethnic+Study+of+Atherosclerosis+(MESA)&amp;author=S+Mora&amp;author=M+Szklo&amp;author=JD+Otvos&amp;author=P+Greenland&amp;author=BM+Psaty&amp;volume=192&amp;publication_year=2007&amp;pages=211-217&amp;pmid=16765964&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al.  Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. <span><span class="ref-journal">Diabetes. </span>2003;<span class="ref-vol">52</span>:453–462.</span> [<a href="/pubmed/12540621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Effects+of+insulin+resistance+and+type+2+diabetes+on+lipoprotein+subclass+particle+size+and+concentration+determined+by+nuclear+magnetic+resonance&amp;author=WT+Garvey&amp;author=S+Kwon&amp;author=D+Zheng&amp;author=S+Shaughnessy&amp;author=P+Wallace&amp;volume=52&amp;publication_year=2003&amp;pages=453-462&amp;pmid=12540621&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, et al.  Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the metabolic syndrome. <span><span class="ref-journal">Lipids Health Dis. </span>2011;<span class="ref-vol">10</span>:143.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3180704/">PMC free article</a>]</span> [<a href="/pubmed/21854610" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lipids+Health+Dis&amp;title=Lipoprotein+lipase+S447X+variant+associated+with+VLDL,+LDL+and+HDL+diameter+clustering+in+the+metabolic+syndrome&amp;author=AC+Wood&amp;author=S+Glasser&amp;author=WT+Garvey&amp;author=EK+Kabagambe&amp;author=IB+Borecki&amp;volume=10&amp;publication_year=2011&amp;pages=143&amp;pmid=21854610&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Sebestjen M, Keber I, Zegura B, Simcic S, Bozic M, Fressart MM, Stegnar M. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. <span><span class="ref-journal">Thromb Haemost. </span>2004;<span class="ref-vol">92</span>:1129–1135.</span> [<a href="/pubmed/15543343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thromb+Haemost&amp;title=Statin+and+fibrate+treatment+of+combined+hyperlipidemia:+the+effects+on+some+novel+risk+factors&amp;author=M+Sebestjen&amp;author=I+Keber&amp;author=B+Zegura&amp;author=S+Simcic&amp;author=M+Bozic&amp;volume=92&amp;publication_year=2004&amp;pages=1129-1135&amp;pmid=15543343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Rosenson RS. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients. <span><span class="ref-journal">Obesity. </span>2009;<span class="ref-vol">17</span>:504–509.</span> [<a href="/pubmed/19023279" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Obesity&amp;title=Effect+of+fenofibrate+on+adiponectin+and+inflammatory+biomarkers+in+metabolic+syndrome+patients&amp;author=RS+Rosenson&amp;volume=17&amp;publication_year=2009&amp;pages=504-509&amp;pmid=19023279&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW. Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome. <span><span class="ref-journal">Atherosclerosis. </span>2008;<span class="ref-vol">198</span>:381–388.</span> [<a href="/pubmed/18242616" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Fenofibrate+reduces+fasting+and+postprandial+inflammatory+responses+among+hypertriglyceridemia+patients+with+the+metabolic+syndrome&amp;author=RS+Rosenson&amp;author=AL+Huskin&amp;author=DA+Wolff&amp;author=IB+Helenowski&amp;author=AW+Rademaker&amp;volume=198&amp;publication_year=2008&amp;pages=381-388&amp;pmid=18242616&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. <span><span class="ref-journal">Am J Med. </span>2002;<span class="ref-vol">112</span>:275–280.</span> [<a href="/pubmed/11893366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med&amp;title=Severe+hypertriglyceridemia+with+insulin+resistance+is+associated+with+systemic+inflammation:+reversal+with+bezafibrate+therapy+in+a+randomized+controlled+trial&amp;author=IJ+Jonkers&amp;author=MF+Mohrschladt&amp;author=RG+Westendorp&amp;author=A+van+der+Laarse&amp;author=AH+Smelt&amp;volume=112&amp;publication_year=2002&amp;pages=275-280&amp;pmid=11893366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Okopien B, Krysiak R, Kowalski J, van der Laarse A, Smelt AH. The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. <span><span class="ref-journal">Atherosclerosis. </span>2004;<span class="ref-vol">176</span>:327–335.</span> [<a href="/pubmed/15380456" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=The+effect+of+statins+and+fibrates+on+interferon-gamma+and+interleukin-2+release+in+patients+with+primary+type+II+dyslipidemia&amp;author=B+Okopien&amp;author=R+Krysiak&amp;author=J+Kowalski&amp;author=A+van+der+Laarse&amp;author=AH+Smelt&amp;volume=176&amp;publication_year=2004&amp;pages=327-335&amp;pmid=15380456&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Knopp RH, Walden CE, Warnick GR, Albers JJ, Ginsberg J, McGinnis BM. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. <span><span class="ref-journal">Am J Med. </span>1987;<span class="ref-vol">83</span>:75–84.</span> [<a href="/pubmed/3120587" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med&amp;title=Effect+of+fenofibrate+treatment+on+plasma+lipoprotein+lipids,+high-density+lipoprotein+cholesterol+subfractions,+and+apolipoproteins+B,+AI,+AII,+and+E&amp;author=RH+Knopp&amp;author=CE+Walden&amp;author=GR+Warnick&amp;author=JJ+Albers&amp;author=J+Ginsberg&amp;volume=83&amp;publication_year=1987&amp;pages=75-84&amp;pmid=3120587&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. <span><span class="ref-journal">Lancet. </span>2001;<span class="ref-vol">357</span>:905–910.</span> [<a href="/pubmed/11289345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect+of+fenofibrate+on+progression+of+coronary-artery+disease+in+type+2+diabetes:+the+Diabetes+Atherosclerosis+Intervention+Study,+a+randomised+study&amp;volume=357&amp;publication_year=2001&amp;pages=905-910&amp;pmid=11289345&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Feher MD, Caslake M, Foxton J, Cox A, Packard CJ. Atherogenic lipoprotein phenotype in type 2 diabetes: reversal with micronised fenofibrate. <span><span class="ref-journal">Diabetes Metab Res Rev. </span>1999;<span class="ref-vol">15</span>:395–399.</span> [<a href="/pubmed/10634964" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Metab+Res+Rev&amp;title=Atherogenic+lipoprotein+phenotype+in+type+2+diabetes:+reversal+with+micronised+fenofibrate&amp;author=MD+Feher&amp;author=M+Caslake&amp;author=J+Foxton&amp;author=A+Cox&amp;author=CJ+Packard&amp;volume=15&amp;publication_year=1999&amp;pages=395-399&amp;pmid=10634964&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Filippatos TD, Gazi IF, Liberopoulos EN, Athyros VG, Elisaf MS, Tselepis AD, Kiortsis DN. The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome. <span><span class="ref-journal">Atherosclerosis. </span>2007;<span class="ref-vol">193</span>:428–437.</span> [<a href="/pubmed/16911813" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=The+effect+of+orlistat+and+fenofibrate,+alone+or+in+combination,+on+small+dense+LDL+and+lipoprotein-associated+phospholipase+A2+in+obese+patients+with+metabolic+syndrome&amp;author=TD+Filippatos&amp;author=IF+Gazi&amp;author=EN+Liberopoulos&amp;author=VG+Athyros&amp;author=MS+Elisaf&amp;volume=193&amp;publication_year=2007&amp;pages=428-437&amp;pmid=16911813&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Vakkilainen J, Steiner G, Ansquer J-C, Perttunen-Nio H, Taskinen MR. Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes. <span><span class="ref-journal">Diabetes Care. </span>2002;<span class="ref-vol">25</span>:627–628.</span> [<a href="/pubmed/11874962" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Fenofibrate+lowers+plasma+triglycerides+and+increases+LDL+particle+diameter+in+subjects+with+type+2+diabetes&amp;author=J+Vakkilainen&amp;author=G+Steiner&amp;author=J-C+Ansquer&amp;author=H+Perttunen-Nio&amp;author=MR+Taskinen&amp;volume=25&amp;publication_year=2002&amp;pages=627-628&amp;pmid=11874962&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Bouly M, Masson D, Gross B, Perttunen-Nio H, Taskinen MR. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:25841–25847.</span> [<a href="/pubmed/11342537" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Induction+of+the+phospholipid+transfer+protein+gene+accounts+for+the+high+density+lipoprotein+enlargement+in+mice+treated+with+fenofibrate&amp;author=M+Bouly&amp;author=D+Masson&amp;author=B+Gross&amp;author=H+Perttunen-Nio&amp;author=MR+Taskinen&amp;volume=276&amp;publication_year=2001&amp;pages=25841-25847&amp;pmid=11342537&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Keating GM, Ormrod D. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia. <span><span class="ref-journal">Drugs. </span>2002;<span class="ref-vol">62</span>:1909–1944.</span> [<a href="/pubmed/12215067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Micronised+fenofibrate:+an+updated+review+of+its+clinical+efficacy+in+the+management+of+dyslipidaemia&amp;author=GM+Keating&amp;author=D+Ormrod&amp;volume=62&amp;publication_year=2002&amp;pages=1909-1944&amp;pmid=12215067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. <span><span class="ref-journal">Circulation. </span>2003;<span class="ref-vol">108</span>:2317–2322.</span> [<a href="/pubmed/14568895" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Inflammatory+markers+and+onset+of+cardiovascular+events:+results+from+the+Health+ABC+study&amp;author=M+Cesari&amp;author=BW+Penninx&amp;author=AB+Newman&amp;author=SB+Kritchevsky&amp;author=BJ+Nicklas&amp;volume=108&amp;publication_year=2003&amp;pages=2317-2322&amp;pmid=14568895&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. <span><span class="ref-journal">Am J Cardiol. </span>2000;<span class="ref-vol">86</span>:943–949.</span> [<a href="/pubmed/11053704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Evidence+that+triglycerides+are+an+independent+coronary+heart+disease+risk+factor&amp;author=P+Cullen&amp;volume=86&amp;publication_year=2000&amp;pages=943-949&amp;pmid=11053704&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. <span><span class="ref-journal">Postgrad Med J. </span>2008;<span class="ref-vol">84</span>:590–598.</span> [<a href="/pubmed/19103817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Postgrad+Med+J&amp;title=Targeting+residual+cardiovascular+risk:+raising+high-density+lipoprotein+cholesterol+levels&amp;author=DJ+Hausenloy&amp;author=DM+Yellon&amp;volume=84&amp;publication_year=2008&amp;pages=590-598&amp;pmid=19103817&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Pankow JS, Province MA, Hunt SC, Arnett DK. Regarding ‘testing for population subdivision and association in four case-control studies’ <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1478–1480.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC378599/">PMC free article</a>]</span> [<a href="/pubmed/12515254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Regarding+‘testing+for+population+subdivision+and+association+in+four+case-control+studies’&amp;author=JS+Pankow&amp;author=MA+Province&amp;author=SC+Hunt&amp;author=DK+Arnett&amp;volume=71&amp;publication_year=2002&amp;pages=1478-1480&amp;pmid=12515254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Frazier-Wood AC, Ordovas JM, Straka RJ, Hixson JE, Borecki IB, Tiwari HK, Arnett DK. The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study. <span><span class="ref-journal">Pharmacogenomics J. </span>2012</span> [Epub ahead of print] <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3410976/">PMC free article</a>]</span> [<a href="/pubmed/22547144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics+J&amp;title=The+PPAR+alpha+gene+is+associated+with+triglyceride,+low-density+cholesterol+and+inflammation+marker+response+to+fenofibrate+intervention:+the+GOLDN+study&amp;author=AC+Frazier-Wood&amp;author=JM+Ordovas&amp;author=RJ+Straka&amp;author=JE+Hixson&amp;author=IB+Borecki&amp;publication_year=2012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. <span><span class="ref-journal">Clin Chem. </span>1992;<span class="ref-vol">38</span>:1632–1638.</span> [<a href="/pubmed/1326420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Development+of+a+proton+nuclear+magnetic+resonance+spectroscopic+method+for+determining+plasma+lipoprotein+concentrations+and+subspecies+distributions+from+a+single,+rapid+measurement&amp;author=JD+Otvos&amp;author=EJ+Jeyarajah&amp;author=DW+Bennett&amp;author=RM+Krauss&amp;volume=38&amp;publication_year=1992&amp;pages=1632-1638&amp;pmid=1326420&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. <span><span class="ref-journal">Clin Lab Med. </span>2006;<span class="ref-vol">26</span>:847–870.</span> [<a href="/pubmed/17110242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Lab+Med&amp;title=Lipoprotein+particle+analysis+by+nuclear+magnetic+resonance+spectroscopy&amp;author=EJ+Jeyarajah&amp;author=WC+Cromwell&amp;author=JD+Otvos&amp;volume=26&amp;publication_year=2006&amp;pages=847-870&amp;pmid=17110242&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Irvin MR, Kabagambe EK, Tiwari HK, Parnell LD, Straka RJ, Tsai M, et al.  Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study. <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2010;<span class="ref-vol">3</span>:462–467.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3119521/">PMC free article</a>]</span> [<a href="/pubmed/20729559" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ+Cardiovasc+Genet&amp;title=Apolipoprotein+E+polymorphisms+and+postprandial+triglyceridemia+before+and+after+fenofibrate+treatment+in+the+Genetics+of+Lipid+Lowering+and+Diet+Network+(GOLDN)+Study&amp;author=MR+Irvin&amp;author=EK+Kabagambe&amp;author=HK+Tiwari&amp;author=LD+Parnell&amp;author=RJ+Straka&amp;volume=3&amp;publication_year=2010&amp;pages=462-467&amp;pmid=20729559&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1253–1260.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2756534/">PMC free article</a>]</span> [<a href="/pubmed/18776909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Integrated+genotype+calling+and+association+analysis+of+SNPs,+common+copy+number+polymorphisms+and+rare+CNVs&amp;author=JM+Korn&amp;author=FG+Kuruvilla&amp;author=SA+McCarroll&amp;author=A+Wysoker&amp;author=J+Nemesh&amp;volume=40&amp;publication_year=2008&amp;pages=1253-1260&amp;pmid=18776909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. <span><span class="ref-journal">Genet Epidemiol. </span>2010;<span class="ref-vol">34</span>:816–834.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3175618/">PMC free article</a>]</span> [<a href="/pubmed/21058334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=MaCH:+using+sequence+and+genotype+data+to+estimate+haplotypes+and+unobserved+genotypes&amp;author=Y+Li&amp;author=CJ+Willer&amp;author=J+Ding&amp;author=P+Scheet&amp;author=GR+Abecasis&amp;volume=34&amp;publication_year=2010&amp;pages=816-834&amp;pmid=21058334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Li Y, Willer CJ, Sanna S, Abecasis GR. Genotype imputation. <span><span class="ref-journal">Annu Rev Genomics Hum Genet. </span>2009;<span class="ref-vol">10</span>:387–406.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2925172/">PMC free article</a>]</span> [<a href="/pubmed/19715440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Genomics+Hum+Genet&amp;title=Genotype+imputation&amp;author=Y+Li&amp;author=CJ+Willer&amp;author=S+Sanna&amp;author=GR+Abecasis&amp;volume=10&amp;publication_year=2009&amp;pages=387-406&amp;pmid=19715440&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Atkinson B, Thereau T. Kinship: mixed-effects Cox models, sparse matrices, and modeling data from large pedigrees. <span><span class="ref-journal">R package version; 1(1.0–17) </span>2007</span> Available at:  <a href="http://www.crantastic.org/packages/kinship" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.crantastic.org/packages/kinship</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al.  LocusZoom: regional visualization of genome-wide association scan results. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>:2336–2337.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2935401/">PMC free article</a>]</span> [<a href="/pubmed/20634204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=LocusZoom:+regional+visualization+of+genome-wide+association+scan+results&amp;author=RJ+Pruim&amp;author=RP+Welch&amp;author=S+Sanna&amp;author=TM+Teslovich&amp;author=PS+Chines&amp;volume=26&amp;publication_year=2010&amp;pages=2336-2337&amp;pmid=20634204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. <span><span class="ref-journal">J R Statist Soc B. </span>1995;<span class="ref-vol">57</span>:289–300.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+R+Statist+Soc+B&amp;title=Controlling+the+false+discovery+rate:+a+practical+and+powerful+approach+to+multiple+testing&amp;author=Y+Benjamini&amp;author=Y+Hochberg&amp;volume=57&amp;publication_year=1995&amp;pages=289-300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Medina I, Montaner D, Bonifaci N, Pujana MA, Carbonell J, Tarraga J, et al.  Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies. <span><span class="ref-journal">Nucleic Acids Res. </span>2009;<span class="ref-vol">37</span>:W340–W344.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2703970/">PMC free article</a>]</span> [<a href="/pubmed/19502494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=Gene+set-based+analysis+of+polymorphisms:+finding+pathways+or+biological+processes+associated+to+traits+in+genome-wide+association+studies&amp;author=I+Medina&amp;author=D+Montaner&amp;author=N+Bonifaci&amp;author=MA+Pujana&amp;author=J+Carbonell&amp;volume=37&amp;publication_year=2009&amp;pages=W340-W344&amp;pmid=19502494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Al-Shahrour F, Arbiza L, Dopazo H, Huerta-Cepas J, Mínguez P, Montaner D, Dopazo J. From genes to functional classes in the study of biological systems. <span><span class="ref-journal">BMC Bioinformatics. </span>2007;<span class="ref-vol">8</span>:114.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1853114/">PMC free article</a>]</span> [<a href="/pubmed/17407596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Bioinformatics&amp;title=From+genes+to+functional+classes+in+the+study+of+biological+systems&amp;author=F+Al-Shahrour&amp;author=L+Arbiza&amp;author=H+Dopazo&amp;author=J+Huerta-Cepas&amp;author=P+Mínguez&amp;volume=8&amp;publication_year=2007&amp;pages=114&amp;pmid=17407596&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">25</span>:25–29.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3037419/">PMC free article</a>]</span> [<a href="/pubmed/10802651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Gene+ontology:+tool+for+the+unification+of+biology.+The+Gene+Ontology+Consortium&amp;author=M+Ashburner&amp;author=CA+Ball&amp;author=JA+Blake&amp;author=D+Botstein&amp;author=H+Butler&amp;volume=25&amp;publication_year=2000&amp;pages=25-29&amp;pmid=10802651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al.  Biological, clinical and population relevance of 95 loci for blood lipids. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">466</span>:707–713.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3039276/">PMC free article</a>]</span> [<a href="/pubmed/20686565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Biological,+clinical+and+population+relevance+of+95+loci+for+blood+lipids&amp;author=TM+Teslovich&amp;author=K+Musunuru&amp;author=AV+Smith&amp;author=AC+Edmondson&amp;author=IM+Stylianou&amp;volume=466&amp;publication_year=2010&amp;pages=707-713&amp;pmid=20686565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Chiang PK, Gordon RK, Tal J, Zeng GC. S-adenosylmethionine and methylation. <span><span class="ref-journal">FASEB J. </span>1996;<span class="ref-vol">10</span>:471–480.</span> [<a href="/pubmed/8647346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=S-adenosylmethionine+and+methylation&amp;author=PK+Chiang&amp;author=RK+Gordon&amp;author=J+Tal&amp;author=GC+Zeng&amp;volume=10&amp;publication_year=1996&amp;pages=471-480&amp;pmid=8647346&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al.  DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2007;<span class="ref-vol">104</span>:19351–19356.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2148293/">PMC free article</a>]</span> [<a href="/pubmed/18042717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=DNA+methylation,+insulin+resistance,+and+blood+pressure+in+offspring+determined+by+maternal+periconceptional+B+vitamin+and+methionine+status&amp;author=KD+Sinclair&amp;author=C+Allegrucci&amp;author=R+Singh&amp;author=DS+Gardner&amp;author=S+Sebastian&amp;volume=104&amp;publication_year=2007&amp;pages=19351-19356&amp;pmid=18042717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma Sadenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. <span><span class="ref-journal">Am J Clin Nutr. </span>2001;<span class="ref-vol">74</span>:723–729.</span> [<a href="/pubmed/11722952" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;title=Plasma+Sadenosylhomocysteine+is+a+more+sensitive+indicator+of+cardiovascular+disease+than+plasma+homocysteine&amp;author=DM+Kerins&amp;author=MJ+Koury&amp;author=A+Capdevila&amp;author=S+Rana&amp;author=C+Wagner&amp;volume=74&amp;publication_year=2001&amp;pages=723-729&amp;pmid=11722952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Calvo D, Gomez-Coronado D, Suarez Y, Lasunción MA, Vega MA. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. <span><span class="ref-journal">J Lipid Res. </span>1998;<span class="ref-vol">39</span>:777–788.</span> [<a href="/pubmed/9555943" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Lipid+Res&amp;title=Human+CD36+is+a+high+affinity+receptor+for+the+native+lipoproteins+HDL,+LDL,+and+VLDL&amp;author=D+Calvo&amp;author=D+Gomez-Coronado&amp;author=Y+Suarez&amp;author=MA+Lasunción&amp;author=MA+Vega&amp;volume=39&amp;publication_year=1998&amp;pages=777-788&amp;pmid=9555943&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Febbraio MA. Null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:19055–19062.</span> [<a href="/pubmed/10383407" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Null+mutation+in+murine+CD36+reveals+an+important+role+in+fatty+acid+and+lipoprotein+metabolism&amp;author=MA+Febbraio&amp;volume=274&amp;publication_year=1999&amp;pages=19055-19062&amp;pmid=10383407&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Oberkofler H, Pfeifenberger A, Soyal S, Felder T, Hahne P, Miller K, et al.  Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans. <span><span class="ref-journal">Diabetologia. </span>2010;<span class="ref-vol">53</span>:1971–1975.</span> [<a href="/pubmed/20461355" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Aberrant+hepatic+TRIB3+gene+expression+in+insulin-resistant+obese+humans&amp;author=H+Oberkofler&amp;author=A+Pfeifenberger&amp;author=S+Soyal&amp;author=T+Felder&amp;author=P+Hahne&amp;volume=53&amp;publication_year=2010&amp;pages=1971-1975&amp;pmid=20461355&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Hoeks J, Hesselink MKC, Russell AP, Mensink M, Saris WH, Mensink RP, Schrauwen P. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. <span><span class="ref-journal">Diabetologia. </span>2006;<span class="ref-vol">49</span>:2419–2426.</span> [<a href="/pubmed/16896940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Peroxisome+proliferator-activated+receptor-gamma+coactivator-1+and+insulin+resistance:+acute+effect+of+fatty+acids&amp;author=J+Hoeks&amp;author=MKC+Hesselink&amp;author=AP+Russell&amp;author=M+Mensink&amp;author=WH+Saris&amp;volume=49&amp;publication_year=2006&amp;pages=2419-2426&amp;pmid=16896940&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Park KS, Shin HD, Park BL, Cheong HS, Cho YM, Lee HK, et al.  Putative association of peroxisome proliferator-activated receptor gamma coactivator 1beta (PPARGC1B) polymorphism with type 2 diabetes mellitus. <span><span class="ref-journal">Diabet Med. </span>2006;<span class="ref-vol">23</span>:635–642.</span> [<a href="/pubmed/16759305" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabet+Med&amp;title=Putative+association+of+peroxisome+proliferator-activated+receptor+gamma+coactivator+1beta+(PPARGC1B)+polymorphism+with+type+2+diabetes+mellitus&amp;author=KS+Park&amp;author=HD+Shin&amp;author=BL+Park&amp;author=HS+Cheong&amp;author=YM+Cho&amp;volume=23&amp;publication_year=2006&amp;pages=635-642&amp;pmid=16759305&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Sun L, Yang Z, Jin F, Zhu XQ, Qu YC, Shi XH, Wang L. The Gly482Ser variant of the PPARGC1 gene is associated with type 2 diabetes mellitus in northern Chinese, especially men. <span><span class="ref-journal">Diabet Med. </span>2006;<span class="ref-vol">23</span>:1085–1092.</span> [<a href="/pubmed/16978372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabet+Med&amp;title=The+Gly482Ser+variant+of+the+PPARGC1+gene+is+associated+with+type+2+diabetes+mellitus+in+northern+Chinese,+especially+men&amp;author=L+Sun&amp;author=Z+Yang&amp;author=F+Jin&amp;author=XQ+Zhu&amp;author=YC+Qu&amp;volume=23&amp;publication_year=2006&amp;pages=1085-1092&amp;pmid=16978372&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, Clarke R, et al.  Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000730.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2777390/">PMC free article</a>]</span> [<a href="/pubmed/19936222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Forty-three+loci+associated+with+plasma+lipoprotein+size,+concentration,+and+cholesterol+content+in+genome-wide+analysis&amp;author=DI+Chasman&amp;author=G+Paré&amp;author=S+Mora&amp;author=JC+Hopewell&amp;author=G+Peloso&amp;volume=5&amp;publication_year=2009&amp;pages=e1000730&amp;pmid=19936222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3760420&amp;issue-id=226992&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139734229867248title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Methods</a></li><li><a href="#S14title">Results</a></li><li><a href="#S18title">Discussion</a></li><li><a href="#S19title">Supplementary Material</a></li><li><a href="#S20title">Acknowledgments</a></li><li><a href="#idm139734195843584title">Footnotes</a></li><li><a href="#idm139734195652608title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3760420/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3760420/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3760420/pdf/nihms487636.pdf">PDF (723K)</a></li> | <li><a href="#" data-citationid="PMC3760420" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3760420%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3760420%2F&amp;text=Genome-wide%20association%20study%20indicates%20variants%20associated%20with%20insulin%20signaling%20and%20inflammation%20mediate%20lipoprotein%20responses%20to%20fenofibrate" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3760420%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22890011" data-aiid="3760420" data-aid="3760420" data-iid="226992" data-domainid="319" data-domain="nihpa" data-accid="PMC3760420" data-md5="5132bb47bf8561d87a468a8f9d0e3547"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T09:24:39-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8AC5B0DD5457C100000000058D0393&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3760420%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3760420/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>